Iterum Therapeutics (ITRM) Shares Outstanding (2017 - 2022)
Historic Shares Outstanding for Iterum Therapeutics (ITRM) over the last 6 years, with Q3 2022 value amounting to $12.2 million.
- Iterum Therapeutics' Shares Outstanding changed N/A to $12.2 million in Q3 2022 from the same period last year, while for Sep 2022 it was $12.2 million, marking a year-over-year change of. This contributed to the annual value of $12.2 million for FY2021, which is 26975.82% up from last year.
- According to the latest figures from Q3 2022, Iterum Therapeutics' Shares Outstanding is $12.2 million.
- Over the past 5 years, Iterum Therapeutics' Shares Outstanding peaked at $14.4 million during Q4 2018, and registered a low of $991265.0 during Q4 2019.
- Over the past 5 years, Iterum Therapeutics' median Shares Outstanding value was $12.2 million (recorded in 2022), while the average stood at $9.6 million.
- As far as peak fluctuations go, Iterum Therapeutics' Shares Outstanding soared by 337414.64% in 2018, and later tumbled by 9309.32% in 2019.
- Over the past 5 years, Iterum Therapeutics' Shares Outstanding (Quarter) stood at $14.4 million in 2018, then tumbled by 93.09% to $991265.0 in 2019, then surged by 232.44% to $3.3 million in 2020, then soared by 269.76% to $12.2 million in 2021, then grew by 0.4% to $12.2 million in 2022.
- Its Shares Outstanding stands at $12.2 million for Q3 2022, versus $12.2 million for Q2 2022 and $12.2 million for Q1 2022.